EML4 and lung carcinoma: Another RT-PCR-based study, by Koivunen et al. [30], showed that 3.6% (6/167) of Korean patients and 1.4% (2/136) of Caucasian patients with lung cancer possessed EML4-ALK variants 1, 3, and 4.